← Every applicant
Renata FDA Approvals
4 new drug approvals and 0 device clearances on file. This applicant is not matched to a listed company.
Newest first
A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.
| Product |
|---|
| CABERGOLINENew drugJun 15, 2026TABLET, ORAL |
| VALSARTANNew drugAug 5, 2024TABLET, ORAL |
| METOLAZONENew drugOct 24, 2022TABLET, ORAL |
| FROVATRIPTAN SUCCINATENew drugApr 6, 2022TABLET, ORAL |